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Introduction
There are two ways to diagnose a disease involving
organs and/or tissues: by morphological detection
or by functional evaluation. Several modern imaging
modalities play a role in the morphological detection
of disease, including ultrasonography, computed
tomography, magnetic resonance imaging, com-
puted radionuclide imaging and angiography. For
the functional assessment of diseases, a number of 
in vitro procedures can be carried out in a well set-up
laboratory, such as analysis of serum free thyroxine
level (FT4) in the evaluation of thyroid function.
Furthermore, in certain circumstances an imaging
modality can also be used to evaluate the function
of an organ, such as left ventricular stroke volume
and cardiac output using contrast ventriculography.
High-resolution real-time ultrasonography is
currently accepted world-wide as a reliable method
in the morphological evaluation of thyroid diseases
[1–6]. However, for the diagnosis of diffuse toxic
goiter (i.e. Graves’ disease), both serum FT4 and
thyroid-stimulating hormone (TSH) levels should
be measured [7]. For the diagnosis of Hashimoto’s
thyroiditis, in addition to FT4 and TSH, the anti-
body titers to thyroglobulin and thyroid peroxidase
are also required [7]. Since Graves’ disease usually
leads to a hyperthyroid state, and the majority of
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It was reported in the literature that increased arterial flow in the thyroid was not only seen
in Graves’ disease with hyperthyroidism, but was also seen in Hashimoto’s thyroiditis with
hypothyroidism. Clinically, increased cardiac output is usually a sign of the former rather
than the latter. Ultrasonographic assessment of the hemodynamic changes in the arteries
of the systemic circulation, therefore, could be of value in differentiating between these
two diffuse autoimmune diseases. Thus, it has been suggested that, for the functional
evaluation of diffuse thyroid diseases, assessment of the peak systolic velocity of the thy-
roid arteries and the common carotid arteries should be performed ultrasonographically.
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Hashimoto’s thyroiditis patients are usually in a
clinically hypothyroid state, the hemodynamic
changes in the cardiovascular system can be an
important sign in differentiating these two diseases
[7]. Using color Doppler ultrasonography (CDUS),
intra-glandular hypervascularity was reported in
diffuse thyroid diseases, irrespective of the hyper-
thyroid, euthyroid or hypothyroid state/phase
[8–21]. Alteration of the hemodynamic kinesis in
the systemic circulation cannot explain the latter
condition. However, why there is increased
parenchymal vascularity in various diffuse thyroid
diseases in spite of the different functional states or
phases is unknown.
Why Hypervascularity in Diffuse
Thyroid Diseases?
Graves’ disease and Hashimoto’s thyroiditis are
autoimmune disorders [7]. Could the hypervascular
pattern, shown as increased color flow by CDUS in
previous reports [8–21], be an inflammatory reac-
tion to autoimmunity of the gland in these diseases?
Several angiogenic factors, including vascular endo-
thelial growth factor [22] and chemokine CXC 
ligand 10 [21], may play an important role in acti-
vating intrathyroid angiogenesis. TSH elevation
and increased TSH receptor antibodies might be
the trigger in the mechanism of angiogenesis in
Hashimoto’s thyroiditis [9,11,23–25]; however, in
Graves’ disease serum TSH is usually low [7]. Both
serum anti-thyroglobulin and anti-thyroid peroxi-
dase antibodies may be increased in Graves’ disease
and Hashimoto’s thyroiditis [7], although they do
not seem to be the main factors in angiogenesis
[25]. Therefore, the true mechanism of hypervas-
cularity in diffuse thyroid diseases is still unknown.
Spectral Doppler Analysis in Diffuse
Thyroid Diseases
Measurement of the peak systolic velocity (PSV) in
the superior and/or inferior thyroid arteries with
spectral Doppler analysis (SDA) also demonstrates
the hemodynamic changes in the thyroid gland
[12–15,21,25–29]. There is a positive correlation
between the qualitative parenchymal blood flow
assessment by CDUS and the quantitative measure-
ment of PSV by SDA of the thyroid gland [21,25,28].
Increased PSV of thyroid arteries was evidenced 
in Graves’ disease [9,12–16,19,20,22,23,25,27–29]
with hyperthyroidism resulting in tachycardia and
high cardiac output [7]. However, PSV elevation in the
thyroid arteries was also evidenced in Hashimoto’s
thyroiditis [11,18,22–25,27] and other thyroid 
diseases, such as simple goiter and goiter with non-
functioning nodule(s) [27], with the possible caus-
ative etiologies of increased thyroid volume [24,27]
and autoimmune inflammatory processes [9–11,
22–25], rather than increased cardiac output itself.
Thus, increased thyroid arterial PSV alone is not a
reliable sign of hyperthyroidism [25], and is inade-
quate for the assessment of thyroid function.
In addition to thyroid arterial PSV measured by
SDA, resistive index has also been reported to be
valuable as a functional index in the follow-up of
medical treatment of Graves’ disease [30]. Yet, it
was recently considered inappropriate in the eval-
uation of post-treatment follow-up of either hyper-
thyroidism [29] or hypothyroidism [25].
Peak Systolic Velocity of Common
Carotid Artery: A Complementary
Indicator of Thyroid Function
In cases without cardiovascular anomaly, the thyroid
functional states may influence cardiovascular hemo-
dynamics, resulting in changes in stroke volume,
heart rate and cardiac output [7]. Hyperthyroidism
is usually associated with increased cardiac output,
tachycardia and, thereafter, increased systemic
arterial blood flow [7]. In contrast, hypothyroidism
manifests with decreased stroke volume, cardiac
output, and bradycardia [7]. Increased cardiac out-
put usually leads to rapid pulse rate and elevated
arterial flow velocity, while decreased cardiac out-
put leads to reduced pulse rate and arterial flow
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velocity. Therefore, measuring flow velocity in the
aorta and its main arterial branches in patients with-
out significant cardiovascular anomaly could be of
value in the evaluation of thyroid function.
The common carotid arteries are the major
branches of the thoracic aorta; their hemodynamic
changes directly reflect the aortic flow kinetics and
cardiac output. Observations of their hemodynam-
ics by CDUS and SDA are easy and convenient prior
to ultrasonographic examination of the thyroid,
because they are close to the gland. A previous ultra-
sonographic study with CDUS and SDA revealed
that increased PSV of the common carotid arteries
occurred in more than 70% of cases with Graves’
disease, and less than 10% of cases with goiter with
nodules and thyroiditis [27]. The results suggest
that increased PSV of the main arteries in the sys-
temic circulation, in combination with increased
thyroid arterial PSV, can be a good indicator in dif-
ferentiating Graves’ disease from other nodular and
diffuse thyroid disease including Hashimoto’s thy-
roiditis. Accordingly, it could be of value to perform
a further ultrasonographic study involving a large
number of cases to assess the functional states of
the thyroid, by measuring the PSV in both the 
thyroid arteries and the common carotid arteries,
in the differential diagnosis of these two diffuse
autoimmune thyroid diseases.
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